Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.37 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6768514 | 0.89 | RAB9A (0.49) | NPC1RAB9AALDH1A1MAPK1NUDT1 | |
| SCHEMBL1576650 | 0.89 | NPC1 (0.62) | NPC1RAB9AALDH1A1MAPK1NUDT1 | |
| SCHEMBL10398846 | 0.82 | CDK1 (0.43) | NPC1RAB9AALDH1A1MAPK1NUDT1 | |
| SCHEMBL8630748 | 0.82 | NPC1 (0.56) | NPC1RAB9AALDH1A1MAPK1NUDT1 | |
| SCHEMBL20606895 | 0.82 | ALDH1A1 (0.44) | NPC1RAB9AALDH1A1MAPK1POLB | |
| SCHEMBL18134205 | 0.82 | NUDT1 (0.66) | NPC1RAB9AALDH1A1MAPK1NUDT1 | |
| SCHEMBL11831023 | 0.82 | ALDH1A1 (0.44) | NPC1RAB9AALDH1A1MAPK1POLB | |
| SCHEMBL8446516 | 0.80 | NPC1 (0.54) | NPC1RAB9AALDH1A1MAPK1NUDT1 | |
| SCHEMBL1576783 | 0.80 | SMN1; SMN2 (0.55) | NPC1RAB9AALDH1A1MAPK1NUDT1 | |
| SCHEMBL16463790 | 0.79 | CDK1 (0.43) | NPC1RAB9AALDH1A1MAPK1NUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026097624-A1 | METHOD FOR PREPARING CHLORINE-RESISTANT NANOFILTRATION MEMBRANE, AND CHLORINE-RESISTANT NANOFILTRATION MEMBRANE PREPARED THEREWITH | 沃顿科技股份有限公司 | 2026-05-15 | — | — | WO | claimed |
| CN-122006472-A | Preparation method of chlorine-resistant nanofiltration membrane and chlorine-resistant nanofiltration membrane prepared by preparation method | 沃顿科技股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-119875059-A | Thermoplastic polyurethane foam material | 万华化学集团股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-111718461-B | Thermoplastic polyurethane elastic fiber and preparation method thereof | 浙江华峰热塑性聚氨酯有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-111718461-A | Thermoplastic polyurethane elastic fiber and preparation method thereof | 浙江华峰热塑性聚氨酯有限公司 | 2020-09-29 | — | — | CN | claimed |
| WO-2026097624-A1 | METHOD FOR PREPARING CHLORINE-RESISTANT NANOFILTRATION MEMBRANE, AND CHLORINE-RESISTANT NANOFILTRATION MEMBRANE PREPARED THEREWITH | 沃顿科技股份有限公司 | 2026-05-15 | — | — | WO | disclosed |
| CN-122006472-A | Preparation method of chlorine-resistant nanofiltration membrane and chlorine-resistant nanofiltration membrane prepared by preparation method | 沃顿科技股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-119875059-A | Thermoplastic polyurethane foam material | 万华化学集团股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-111718461-B | Thermoplastic polyurethane elastic fiber and preparation method thereof | 浙江华峰热塑性聚氨酯有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-111718461-A | Thermoplastic polyurethane elastic fiber and preparation method thereof | 浙江华峰热塑性聚氨酯有限公司 | 2020-09-29 | — | — | CN | disclosed |
| EP-2035419-B1 | 5-ARYL-SUBSTITUTED DIHYDROPYRIDOPYRIMIDINES AND DIHYDROPYRIDAZINES AND USE THEREOF AS MINERAL CORTICOID ANTAGONISTS | BAYER IP GMBH (DE) | 2016-06-22 | — | — | EP | disclosed |
| EP-2035419-B1 | 5-ARYL-SUBSTITUTED DIHYDROPYRIDOPYRIMIDINES AND DIHYDROPYRIDAZINES AND USE THEREOF AS MINERAL CORTICOID ANTAGONISTS | BAYER IP GMBH (DE) | 2016-06-22 | — | — | EP | disclosed |
| US-20060189620-A1 | Immunosuppressive effects of pteridine derivatives | 4 AZA BIOSCIENCE NV (BE) | 2006-08-24 | — | — | US | disclosed |
| EP-1663244-A2 | PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-ALPHA-RELATED DISEASES. | 4 AZA Bioscience nv (BE) | 2006-06-07 | — | — | EP | disclosed |
| EP-1658081-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA Bioscience nv (BE) | 2006-05-24 | — | — | EP | disclosed |
| EP-1594902-A1 | MOLECULARY IMPRINTED POLYMERS FOR EXTRACTION OF COMPONENTS FROM FOODSTRUFFS | MIP Technologies AB (SE) | 2005-11-16 | — | — | EP | disclosed |
| WO-2005025574-A2 | PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. | 4 AZA BIOSCIENCE NV (BE) | 2005-03-24 | — | — | WO | disclosed |
| WO-2005021003-A2 | IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | 4 AZA BIOSCIENCE NV (BE) | 2005-03-10 | — | — | WO | disclosed |
| WO-2004067578-A1 | MOLECULARY IMPRINTED POLYMERS FOR EXTRACTION OF COMPONENTS FROM FOODSTRUFFS | MIP TECHNOLOGIES AB (SE) | 2004-08-12 | — | — | WO | disclosed |
| US-20040077859-A1 | Immunosuppressive effects of pteridine derivatives | 4 AZA BIOSCIENCE NV (BE) | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077859-A1 | Immunosuppressive effects of pteridine derivatives | TPMT, NFATC1, MALT1 | NPC1 1701/4885RAB9A 1698/4885ALDH1A1 1257/4885 |
| US-20060189620-A1 | Immunosuppressive effects of pteridine derivatives | TPMT, NFATC1, MALT1 | NPC1 1701/4885RAB9A 1698/4885ALDH1A1 1257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.